Anticoagulation for Ablation Procedures

Michael C. Giudici; Bria Giacomino

doi:10.1016/B978-0-323-55429-9.00010-8

Anticoagulation for Ablation Procedures

Michael C. Giudici, Bria Giacomino

Division of Cardiology

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

In this chapter, we walk through an atrial fibrillation ablation and discuss the recommendations and rationale for managing anticoagulation before, during, and after the procedure. We address the use of warfarin, the novel anticoagulants, heparin, protamine, and low molecular weight heparin and how to minimize risk of thrombus while still avoiding hemorrhagic complications.

Original language	English
Title of host publication	Stroke Prevention in Atrial Fibrillation
Publisher	Elsevier
Pages	129-131
Number of pages	3
ISBN (Electronic)	9780323554299
ISBN (Print)	9780323554305
DOIs	https://doi.org/10.1016/B978-0-323-55429-9.00010-8
State	Published - Jan 1 2018

Keywords

Atrial fibrillation ablation
Heparin
Novel anticoagulants
Warfarin

Access to Document

10.1016/B978-0-323-55429-9.00010-8

Cite this

@inbook{745fe13ba719402d8934fe68ad4abeb0,

title = "Anticoagulation for Ablation Procedures",

abstract = "In this chapter, we walk through an atrial fibrillation ablation and discuss the recommendations and rationale for managing anticoagulation before, during, and after the procedure. We address the use of warfarin, the novel anticoagulants, heparin, protamine, and low molecular weight heparin and how to minimize risk of thrombus while still avoiding hemorrhagic complications.",

keywords = "Atrial fibrillation ablation, Heparin, Novel anticoagulants, Warfarin",

author = "Giudici, {Michael C.} and Bria Giacomino",

year = "2018",

month = jan,

day = "1",

doi = "10.1016/B978-0-323-55429-9.00010-8",

language = "English",

isbn = "9780323554305",

pages = "129--131",

booktitle = "Stroke Prevention in Atrial Fibrillation",

publisher = "Elsevier",

}

TY - CHAP

T1 - Anticoagulation for Ablation Procedures

AU - Giudici, Michael C.

AU - Giacomino, Bria

PY - 2018/1/1

Y1 - 2018/1/1

N2 - In this chapter, we walk through an atrial fibrillation ablation and discuss the recommendations and rationale for managing anticoagulation before, during, and after the procedure. We address the use of warfarin, the novel anticoagulants, heparin, protamine, and low molecular weight heparin and how to minimize risk of thrombus while still avoiding hemorrhagic complications.

AB - In this chapter, we walk through an atrial fibrillation ablation and discuss the recommendations and rationale for managing anticoagulation before, during, and after the procedure. We address the use of warfarin, the novel anticoagulants, heparin, protamine, and low molecular weight heparin and how to minimize risk of thrombus while still avoiding hemorrhagic complications.

KW - Atrial fibrillation ablation

KW - Heparin

KW - Novel anticoagulants

KW - Warfarin

UR - http://www.scopus.com/inward/record.url?scp=85142099319&partnerID=8YFLogxK

U2 - 10.1016/B978-0-323-55429-9.00010-8

DO - 10.1016/B978-0-323-55429-9.00010-8

M3 - Chapter

AN - SCOPUS:85142099319

SN - 9780323554305

SP - 129

EP - 131

BT - Stroke Prevention in Atrial Fibrillation

PB - Elsevier

ER -

Anticoagulation for Ablation Procedures

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this